ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesLicensing & Marketing of Intellectual PropertyZugCorcept Therapeutics Switzerland GmbH
Corcept Therapeutics Switzerland GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Corcept Therapeutics Switzerland GmbH is a biopharmaceutical company focused on cortisol modulation and the development of related therapies. The company researches and develops compounds for serious diseases, with clinical programs in endocrinology, oncology, metabolism, and neurology.

AI-generated
Offering

Products & services

Industry:Licensing & Marketing of Intellectual Property
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.9/5

Corcept Therapeutics Switzerland GmbH

Research & Development
Pharmaceutical Industry
✓ Offered7
Cortisol Modulation Therapies
Cortisol modulation therapies for serious diseases, especially hypercortisolism, oncology, metabolic disorders and neurological diseases; research, clinical trials and development of new compounds.
Hypercortisolism Medicines
Medicines for hypercortisolism (Cushing syndrome), including Korlym and Lifyorli; medical information, product information and related support resources.
Clinical Trials
Clinical trials of Corcept compounds in endocrinology, oncology, metabolism and neurology; ongoing Phase I to Phase IV studies and access to trial information.
Expanded Access to Investigational Medicines
Expanded access to investigational medicines for patients with serious or life-threatening diseases when no suitable trial or alternative treatment is available and eligibility criteria are met.
Medical Information Request
Medical inquiries about Korlym, Lifyorli and other products; information for healthcare professionals, patients, caregivers and pharmacists via form or contact channels.
Research Grants
Independent research and educational funding for medical and patient education, supporting hospitals, academic centers, professional societies and patient advocacy groups.
Investigator-Initiated Studies
Support for research projects on Corcept medicines through medication, funding and subject-matter expertise; concept proposals submitted via the submission portal.
Trust & reputation

ranQ Trust Score of Corcept Therapeutics Switzerland GmbH: 3.9 out of 5.0

Trust Score3.9/ 5.0

High

x

Data basis 54% · As of October 2026

Corcept Therapeutics Switzerland GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Corcept Therapeutics Switzerland GmbH scores 50.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.25.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Corcept Therapeutics Switzerland GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Corcept Therapeutics Switzerland GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Corcept Therapeutics Switzerland GmbH reaches a ranQ Trust Score of 3.9 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Corcept Therapeutics Switzerland GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Corcept Therapeutics Switzerland GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Corcept Therapeutics Switzerland GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Corcept Therapeutics Switzerland GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Grafenauweg 8
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-490.010.718
Founded
2025 · 1 year
Last commercial register change
October 23, 2025
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.88.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    EL
    E2 Life Sciences AG
    Zug
    NI
    Noveeda International GmbH
    Zug
    AE
    Aesara Europe GmbH
    Zug
    BL
    Brand Loyalty Worldwide GmbH
    Zug
    BG
    Bookatrekking.com GmbH
    Zug
    TR
    Thomson Reuters Global Resources Unlimited Company, Dublin, Zweigniederlassung Zug
    Zug
    SA
    STOXX AG
    Zug
    AW
    Access World AG
    Zug